How to Get Your GLP-1 for $50 a Month on Medicare
Medicare's GLP-1 Bridge gives eligible Part D members Wegovy, Zepbound, or Foundayo for a flat $50 a month. Here's who qualifies, how to actually get it, and the four mistakes sending people home empty-handed.
For years the answer for a Medicare patient who wanted a GLP-1 for weight was simply no. Medicare Part D was barred from covering weight-loss drugs, so unless you had type 2 diabetes, you were looking at paying cash.
That changed on July 1, 2026. The Medicare GLP-1 Bridge is a temporary CMS program that gives eligible Part D members certain GLP-1 medications for a flat $50 per 30-day supply. It runs through December 31, 2027.
It is real, it is working, and — going by what pharmacists have been reporting since it opened — a lot of people who qualify are being turned away at the counter for reasons that have nothing to do with whether they're eligible.
Key point
The single most useful thing to know: your first claim is supposed to get rejected. That rejection is how the program starts, not a denial. People who don't know that walk out of the pharmacy assuming they were refused.
What's covered
Three medications:
- Wegovy (semaglutide) — both the injection and the tablets
- Zepbound (tirzepatide) — the KwikPen only. Single-dose vials and single-dose pens are not covered. This one catches people out.
- Foundayo (orforglipron) — covered broadly across its formulations
Ozempic and Mounjaro are not on the list. Those are the diabetes-indicated versions, and diabetes is handled by regular Part D coverage instead — see the exclusions below.
Who qualifies
Eligibility is tiered by BMI, and there's an important detail: it's your BMI when you first started GLP-1 therapy, not your BMI today. If the medication has been working, those are different numbers, and using the current one is one of the most common reasons a request gets kicked back.
| Tier | BMI | Also need? |
|---|---|---|
| 1 | 35 or higher | Nothing else — you qualify on BMI alone |
| 2 | 30 or higher | One qualifying condition (for example, uncontrolled high blood pressure) |
| 3 | 27 or higher | One qualifying condition from your history (for example, pre-diabetes) |
You also have to be enrolled in a Medicare Part D plan. Your plan doesn't have to participate — the Bridge runs outside Part D entirely, so your plan can't opt out of it on your behalf.
Who doesn't qualify
You are not eligible through the Bridge if you have:
- Type 2 diabetes
- Moderate-to-severe obstructive sleep apnea
- Noncirrhotic MASH (metabolic dysfunction-associated steatohepatitis)
This sounds like bad news and usually isn't. Those three are already covered indications under regular Part D — your plan is supposed to cover a GLP-1 for them the normal way. The Bridge exists specifically for people whose only indication is weight, which Part D couldn't cover. If you have one of those diagnoses, the route is your plan, not this program.
You're also not eligible if you're already getting a GLP-1 covered through your Part D plan. You can't have it both ways.
How to actually get it
This is where it goes wrong for people, so here it is in order.
1. Talk to your prescriber. They submit a prior authorization request and the prescription to CMS's central processor — not to your Part D plan. Your plan is not involved in this. Your prescriber has to attest that you meet the clinical criteria, which means they need your BMI at the time you started therapy in the record.
2. Expect the first claim to reject. When the pharmacy runs it, the claim rejects at your Part D plan. That is the designed trigger for the prior authorization — it is not a coverage decision and it is not a no. A rejection notice at this stage means the process is working.
3. Make sure the pharmacy routes it correctly. The Bridge has its own billing route, separate from your usual Part D coverage. If the pharmacy submits it through your normal Part D BIN/PCN, it produces something that looks exactly like a denial but never reaches the Bridge processor at all. The Bridge route is BIN 028918 / PCN MEDDGLP1BR.
Tip
If your pharmacist says it was denied, it is worth asking — politely — whether it was submitted through the GLP-1 Bridge BIN and PCN. This is a new program, and a routing mistake and a real denial look identical from the customer side of the counter. Writing those two values down before you go is a two-minute step that has saved people a wasted trip.
4. Pay $50. Once it's approved and routed, it's a flat $50 for each 30-day supply.
Four things that get people bounced
Based on what pharmacies have reported since the program opened, the holdups cluster:
- The prior authorization was submitted before a rejected claim was on file. The rejection has to come first — it's the trigger.
- The form listed current BMI instead of BMI at initiation. Worth checking with your prescriber's office directly.
- A Part D-eligible diagnosis was sent to the Bridge. If you have diabetes, sleep apnea, or MASH on your chart, that prescription belongs in the Part D lane.
- Incomplete form fields. Mundane, and apparently common.
None of these are about whether you qualify. All of them are fixable by asking the right question.
Two things worth knowing before you budget
The $50 is flat, and Low-Income Subsidy protections don't apply. If you normally have Extra Help reducing your copays, it does not reduce this one. For most people $50 is dramatically better than cash price. For someone with an LIS who is used to paying a few dollars, it is worth doing the arithmetic rather than assuming.
It's temporary. The Bridge ends December 31, 2027. It is a demonstration program, not a permanent benefit, and what replaces it — if anything — hasn't been decided. That's not a reason to skip it. It is a reason to have a conversation with your prescriber about what the plan looks like after, rather than being surprised in eighteen months.
The honest summary
If you're on Medicare, your BMI at the time you started was 27 or higher, you don't have diabetes or sleep apnea on your chart, and you're enrolled in Part D — you can probably get Wegovy, Zepbound KwikPen, or Foundayo for $50 a month right now.
The medicine is the easy part. The paperwork is where people lose, and mostly to four specific, fixable mistakes.
Important
This is general information, not medical or benefits advice, and program rules can change. Confirm your own eligibility and the current requirements with your prescriber and with Medicare directly at medicare.gov or 1-800-MEDICARE. GLTrax is not affiliated with Medicare or CMS and cannot enroll you or submit anything on your behalf.
Once you're on it, the next questions are usually about side effects. Our posts on fatigue and feeling cold and what the research says about muscle loss cover the two that come up most — and muscle matters more, not less, over 65.
This article is general education, not medical advice. Talk to your healthcare provider about your own treatment.